A sponsor is underwriting the acquisition of an Indonesian cold-chain operator with multiple operating entities and a regional parent structure. The transaction team needs to determine whether the acquisition triggers Indonesian merger notification requirements — and whether any resulting exposure is sufficiently evidenced to enter the financial model.
01. Regulatory Gate: Post-Closing Merger Notification and Threshold Framework
Indonesia operates a post-closing merger notification regime. A qualifying acquisition may require notification to KPPU within 30 working days from the date the transaction becomes legally effective, subject to applicable conditions and statutory thresholds [1].
| Regulatory Condition | Evidence State | State |
|---|---|---|
| Change of control structure | Binding SPA | VERIFIED |
| Indonesian group assets | Not provided | MISSING |
| Indonesian group sales | IM: IDR 4.8T / Factbook: IDR 5.4T | CONFLICT |
| Affiliate / control relationship | Corporate structure | VERIFIED |
| Legal effective date | Transaction documentation | VERIFIED |
02. Evidence Conflict & RFI Generation
Cross-referencing the data room reveals a material contradiction across financial records:
The engine does not average out the discrepancy or select the safer figure. Because the available evidence produces conflicting threshold outcomes, notification applicability remains unresolved.
03. Financial Underwriting Treatment
Because regulatory applicability remains unresolved and the supporting evidence is incomplete or conflicted, the engine gates downstream financial modeling:
| Underwriting Output | State |
|---|---|
| Regulatory exposure | CONDITIONAL |
| Applicability | UNRESOLVED |
| Financial exposure | UNQUANTIFIED |
| Valuation | BLOCKED |
| Transaction allocation | PENDING |
AseanPrimer structures the KPPU analysis as a traceable sequence: Condition → Evidence → Conflict → RFI → Financial Status → Transaction Allocation. The objective is not to replace legal or competition-law review, but to prevent unresolved regulatory evidence from being propagated into the financial model. No regulatory cost, reserve, or escrow assumption is inserted into the valuation model until the underlying evidence is sufficiently resolved.